首页>
外国专利>
Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
展开▼
机译:治疗年龄相关的黄斑变性(AMD)和致病眼血管化
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present application is directed to the use of a VEGF-C inhibitor, a VEGFR-2 inhibitor and/or a VEGFR-3 inhibitor as a prophylactic or therapeutic for the treatment of eye disorders such as a maculopathy and pathogenic ocular neovascularisation. The application is also directed to the use of a VEGF-C measurement from a biological sample from a mammalian subject as a predictive marker, a selected marker, a responsive marker or a tracking marker for a disease or condition selected from the group consisting of a maculopathy and pathogenic ocular neovascularization.
展开▼